{"brief_title": "A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment", "brief_summary": "The purpose of this study is to test the safety and effectiveness of a new non-nucleoside reverse transcriptase inhibitor (NNRTI), (+)-calanolide A, in HIV-positive patients who have never received anti-HIV treatment.", "detailed_description": "Patients are randomized into 2 cohorts, with Cohort 2 receiving a higher dosage than Cohort 1. Patients in each cohort receive either (+)-calanolide A or a placebo for 14 days, followed by a 14-day follow-up period. Following study treatment, patients may elect to receive an open-label, 6-month course of anti-HIV drugs to be selected by and administered under the care of the patient's physician.", "condition": ["HIV Infections"], "intervention_type": ["Drug"], "intervention_name": ["Calanolide A"], "criteria": "Inclusion Criteria You may be eligible for this study if you: - Are HIV-positive. - Have a CD4 count of at least 250 cells/mm3. - Have an HIV count (viral load) of at least 5,000 copies/ml. - Are at least 18 years old. Exclusion Criteria You will not be eligible for this study if you: - Have received prescription or nonprescription medications within 14 days of study entry, or if you will need to take any of these medications during the study. - Have ever received anti-HIV medications. - Test positive for hepatitis B. - Have received a blood (or red blood cell) transfusion within 3 months prior to study entry. - Have severe diarrhea. - Have severe heart, liver, kidney, or neurological (brain and spinal cord) disease. - Have hemophilia or another blood disorder. - Have received certain medications or vaccines within 30 days prior to study entry. - Have received chemotherapy or radiation within 16 days prior to study entry, or if you will need either of these during the study.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Anti-HIV Agents", "mesh_term": ["HIV Infections", "Reverse Transcriptase Inhibitors", "Calanolide A"], "id": "NCT00002243"}